Recombinant Human LGALS1 (C-6His)

Produktübersicht

• Artikelname: Recombinant Human LGALS1 (C-6His)
• Artikelnummer: EBT-EPT022
• Hersteller Artikelnummer: EPT022
• Alternativnummer: EBT-EPT022-50
• Hersteller: ELK Biotechnology
• Kategorie: Proteine/Peptide
• Alternative Synonym: Galectin-1, Gal-1, 14 kDa Laminin-Binding Protein, HLBP14, 14 kDa Lectin, Beta-Galactoside-Binding Lectin L-14-I, Galaptin, HBL, HPL, Lactose-Binding Lectin 1, Lectin Galactoside-Binding Soluble 1, Putative MAPK-Activating Protein PM12, S-Lac Lectin 1, LGALS1

Produktbeschreibung

Recombinant Human Galectin-1 is produced by our E.coli expression system and the target gene encoding Ala2-Asp135 is expressed with a 6His tag at the C-terminus.

Produkteigenschaften

• Molekulargewicht: Molecular weight: 15.78 KDa. Apparent molecular weight: 15 KDa, reducing conditions
• UniProt: P09382
• Reinheit: Greater than 95% as determined by reducing SDS-PAGE.

Anwendungsbeschreibung

• Anwendungsbeschreibung: Redissolve: Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100µg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.. Endotoxin: Less than 0.1 ng/µg (1 EU/µg) as determined by LAL test. Background: Galectin-1 is a member of growing family of evolutionary conserved animal lectins. Galectin-1 is widely expressed in many cells and tissues. Galectins consists of a Galectin domain and two Beta-galactoside binding domains. Galectin-1 can binds LGALS3BP and interacts with CD2, CD3, CD4, CD7, CD43 and CD45. Galectin-1 may act as an autocrine negative growth factor which regulates apoptosis, cell proliferation and cell differentiation. In addition, Galectin-1 plays improtant roles in immunosuppressive and antiinflammatory properties